W4205968426

• Experimental glycopeptide antibiotic EVG7 prevents recurrent Clostridioides difficile infection by sparing members of the Lachnospiraceae family

  2025 Nature Communications article Medicine Clostridium difficile and Clostridium perfringens research Open access

  3

  citations
• Manufacture of Clostridioides difficile spores for experimental infection of human volunteers

  2025 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Clostridium difficile and Clostridium perfringens research Open access

  0

  citations
• Risk factors and outcomes of Clostridioides difficile infection in patients with colorectal cancer: critical perspective in management

  2025 Gut Pathogens article Medicine Clostridium difficile and Clostridium perfringens research Open access

  8

  citations
• Enabling next-generation anaerobic cultivation through biotechnology to advance functional microbiome research

  2025 Nature Biotechnology article Biochemistry, Genetics and Molecular Biology Gut microbiota and health

  18

  citations
• Clostridioides difficile is a bacterial priority pathogen

  2025 Anaerobe article Medicine Clostridium difficile and Clostridium perfringens research Open access

  13

  citations
• The New Horizon of Clostridioides difficile Infection Treatment

  2024 Gastroenterology article Medicine Clostridium difficile and Clostridium perfringens research

  2

  citations
• How to develop a controlled human infection model for Clostridioides difficile

  2024 Clinical Microbiology and Infection article Medicine Clostridium difficile and Clostridium perfringens research Open access

  6

  citations
• Fine-tuning the gut ecosystem: the current landscape and outlook of artificial microbiome therapeutics

  2024 ˜The œLancet. Gastroenterology & hepatology article Biochemistry, Genetics and Molecular Biology Gut microbiota and health

  39

  citations
• European Practice for CDI Treatment

  2024 Advances in experimental medicine and biology book-chapter Medicine Clostridium difficile and Clostridium perfringens research

  4

  citations
• Update on microbiota-derived therapies for recurrent Clostridioides difficile infections

  2023 Clinical Microbiology and Infection article Medicine Clostridium difficile and Clostridium perfringens research Open access

  31

  citations
• 2’-Fucosyllactose inhibits proliferation of Clostridioides difficile ATCC 43599 in the CDi-screen, an in vitro model simulating Clostridioides difficile infection

  2022 Frontiers in Cellular and Infection Microbiology article Medicine Clostridium difficile and Clostridium perfringens research Open access

  16

  citations

11 results